ATE202111T1 - Platinkomplexe - Google Patents

Platinkomplexe

Info

Publication number
ATE202111T1
ATE202111T1 AT96300601T AT96300601T ATE202111T1 AT E202111 T1 ATE202111 T1 AT E202111T1 AT 96300601 T AT96300601 T AT 96300601T AT 96300601 T AT96300601 T AT 96300601T AT E202111 T1 ATE202111 T1 AT E202111T1
Authority
AT
Austria
Prior art keywords
carboxylate
hydroxy
platinum complexes
different
halo
Prior art date
Application number
AT96300601T
Other languages
German (de)
English (en)
Inventor
Barry A Murrer
Original Assignee
Anormed Inc
Cancer Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc, Cancer Res Inst filed Critical Anormed Inc
Application granted granted Critical
Publication of ATE202111T1 publication Critical patent/ATE202111T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Studio Devices (AREA)
AT96300601T 1995-02-14 1996-01-29 Platinkomplexe ATE202111T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502799.1A GB9502799D0 (en) 1995-02-14 1995-02-14 Improvements in platinum complexes

Publications (1)

Publication Number Publication Date
ATE202111T1 true ATE202111T1 (de) 2001-06-15

Family

ID=10769529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96300601T ATE202111T1 (de) 1995-02-14 1996-01-29 Platinkomplexe

Country Status (19)

Country Link
US (2) US5665771A (fi)
EP (1) EP0727430B1 (fi)
JP (1) JP3219235B2 (fi)
KR (1) KR100339866B1 (fi)
AT (1) ATE202111T1 (fi)
AU (1) AU707814B2 (fi)
CA (1) CA2169019C (fi)
DE (1) DE69613254T2 (fi)
DK (1) DK0727430T3 (fi)
ES (1) ES2157399T3 (fi)
FI (1) FI120493B (fi)
GB (1) GB9502799D0 (fi)
GR (1) GR3036513T3 (fi)
HK (1) HK1011997A1 (fi)
NO (1) NO307569B1 (fi)
NZ (1) NZ280946A (fi)
PT (1) PT727430E (fi)
TW (1) TW432068B (fi)
ZA (1) ZA96885B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001872A (en) * 1999-03-05 1999-12-14 Virginia Commonwealth University Water soluble transplatinum complexes with anti-cancer activity and method of using same
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
WO2000061590A1 (en) * 1999-04-13 2000-10-19 Anormed, Inc. Process for preparing amine platinum complexes
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6894049B1 (en) 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
WO2003017998A1 (en) * 2001-08-23 2003-03-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Platinum complexes and their use in cancer treatment
WO2007021852A2 (en) * 2005-08-11 2007-02-22 Virginia Commonwealth University Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) * 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
BRPI0806418A2 (pt) * 2007-02-09 2011-09-06 Poniard Pharmaceuticals Inc formas de dosagem oral para picoplatina, série de granulados revestidos, processo para preparar uma forma de dosagem oral para picoplatina e métodos de tratamentos do cáncer
AU2008214199A1 (en) * 2007-02-09 2008-08-14 Poniard Pharmaceuticals, Inc. Encapsulated picoplatin
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
EP2178893A4 (en) * 2007-07-16 2012-09-19 Poniard Pharmaceuticals Inc ORAL FORMULATIONS FOR PICOPLATIN
CN102014624A (zh) * 2008-02-08 2011-04-13 帕纳德制药公司 治疗肺癌的吡铂和氨柔比星
CN101775040B (zh) * 2009-12-31 2012-05-09 南京臣功制药有限公司 吡铂的制备方法
WO2015009841A2 (en) * 2013-07-16 2015-01-22 Blend Therapeutics Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof
CN106943343B (zh) * 2016-01-06 2020-05-12 山东新时代药业有限公司 一种甲啶铂注射液及其制备方法
US10987353B2 (en) 2016-05-04 2021-04-27 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
KR840007599A (ko) * 1983-01-21 1984-12-08 마쓰바라 이찌로오 백금 착화합 유기물의 제조방법
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
ATE63919T1 (de) * 1984-06-27 1991-06-15 Johnson Matthey Plc Platinkoordinationsverbindungen.
JPS61238795A (ja) * 1985-04-16 1986-10-24 エンゲルハード・コーポレーシヨン 白金トリアミン抗腫瘍剤
US4902797A (en) * 1986-12-18 1990-02-20 Shionogi & Co., Ltd. Ammine-alicyclic amine-platinum complexes and antitumor agents
US4812193A (en) * 1986-12-22 1989-03-14 Gauron Richard F Inset panel fastener and method of using
DE68918878T2 (de) * 1988-02-02 1995-02-23 Johnson Matthey Inc Pt(IV) Komplexe.
GB8806044D0 (en) * 1988-03-14 1988-04-13 Johnson Matthey Plc Platinum coordination compounds
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
US5624919A (en) * 1993-09-14 1997-04-29 The University Of Vermont And State Agricultural College Trans platinum (IV) complexes
GB9408218D0 (en) * 1994-04-26 1994-06-15 Johnson Matthey Plc Improvements in platinum complexes
WO2000061590A1 (en) * 1999-04-13 2000-10-19 Anormed, Inc. Process for preparing amine platinum complexes
WO2003017998A1 (en) * 2001-08-23 2003-03-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Platinum complexes and their use in cancer treatment
ES2327346T3 (es) * 2004-09-01 2009-10-28 Platco Technologies (Proprietary) Limited Preparacion de complejos de platino (ii).
WO2007021852A2 (en) * 2005-08-11 2007-02-22 Virginia Commonwealth University Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents

Also Published As

Publication number Publication date
KR960030940A (ko) 1996-09-17
JP3219235B2 (ja) 2001-10-15
JPH08259581A (ja) 1996-10-08
DK0727430T3 (da) 2001-09-03
CA2169019A1 (en) 1996-08-15
USRE41209E1 (en) 2010-04-06
NO960569L (no) 1996-08-15
ZA96885B (en) 1996-08-14
PT727430E (pt) 2001-11-30
DE69613254D1 (de) 2001-07-19
FI960660A0 (fi) 1996-02-14
AU4225896A (en) 1996-08-22
DE69613254T2 (de) 2001-09-20
FI120493B (fi) 2009-11-13
GB9502799D0 (en) 1995-04-05
EP0727430B1 (en) 2001-06-13
CA2169019C (en) 2003-02-04
TW432068B (en) 2001-05-01
AU707814B2 (en) 1999-07-22
FI960660A (fi) 1996-08-15
EP0727430A1 (en) 1996-08-21
US5665771A (en) 1997-09-09
NO960569D0 (no) 1996-02-13
NZ280946A (en) 1997-05-26
GR3036513T3 (en) 2001-12-31
KR100339866B1 (ko) 2002-11-07
ES2157399T3 (es) 2001-08-16
NO307569B1 (no) 2000-04-25
HK1011997A1 (en) 1999-07-23

Similar Documents

Publication Publication Date Title
ATE202111T1 (de) Platinkomplexe
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
ATE205216T1 (de) Platinkomplexe
ES8701707A1 (es) Procedimiento para preparar derivados del acido acrilico conactividad fungicida
DK0952148T3 (da) Cyclobutylaryloxyarylsulfonylaminohydroxamsyrederivater
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
BR0211422A (pt) Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto
DE69533043D1 (de) Acrylamid-derivate und verfahren zu deren herstellung
DE3677092D1 (de) Emulsionen zur entseuchung giftiger, chemischer mittel, deren herstellung und verwendung.
ATE69604T1 (de) Verfahren zur herstellung von 1-hydroxy-2pyridonen.
DE69704716D1 (de) Zusammensetzung und deren verwendung
DE3678086D1 (de) Rhizoxinderivate, ihre herstellung und pharmazeutische verwendung.
DE68901024D1 (de) Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
DE69319356D1 (de) Thiolderivate von Gallensäure
TR199701744T1 (xx) Ha�arat m�cadele maddesi olarak s�bstit�e edilmi� 1,3-Dioksan-5-�lamino-Heterosayk�llar�.
DE69415700T2 (de) Strahlungsenergievorrichtung für die mikroklimatische Regulierung von isolierten Umgebungen bestimmt für Aquikultur, Hydrokultur und Gewächshauskultur
TH19367A (th) ซับสทิทิวเทค 2-เฟนิล พิริดีน
SU1823440A1 (ru) N-производные 3,3-бис-(4-оксиарил)индолин-2-она в качестве модификаторов поликарбоната
TR200100476T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
TH29868A (th) วิธีการและองค์ประกอบของสารสำหรับทำให้สีของผิวหนังจางลง
ES8704891A1 (es) Procedimiento para la obtencion de n-halogenoalquilsulfenil-(tio)-carbamatos
BG51718A1 (en) 1-aryl-3-furfuryl-carbamides,method for their preparation and their application
DE60025821D1 (de) Any-rf gen, wachstumsrühe regulierende substanz, verfahren zu seiner herstellungund zellregulator fur lebende zellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification